Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
0.020 GeneticVariation disease BEFREE After adjusting for possible confounding factors, COX-2 -765C allele vs. -765G/G genotype (OR=0.22, 95%CI=0.12-0.39) was a protective factor against OSCC development, but was a risk factor for malignant potential of OSF (OR=3.20, 95%CI=1.32-8.94) and OL (OR=6.73, 95%CI=2.84-19.87). 18234542 2008
Entrez Id: 4513
Gene Symbol: COX2
COX2
0.020 GeneticVariation disease BEFREE After adjusting for possible confounding factors, COX-2 -765C allele vs. -765G/G genotype (OR=0.22, 95%CI=0.12-0.39) was a protective factor against OSCC development, but was a risk factor for malignant potential of OSF (OR=3.20, 95%CI=1.32-8.94) and OL (OR=6.73, 95%CI=2.84-19.87). 18234542 2008
Entrez Id: 4314
Gene Symbol: MMP3
MMP3
0.020 GeneticVariation disease BEFREE The results indicated that the 5A genotype of MMP3 promoter was associated with the risk of OSF but not OSCC. 16430740 2006
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1
0.020 GeneticVariation disease BEFREE Our results suggest that polymorphism in CYP1A1 and CYP2E1 may confer an increased risk for Oral Submucous Fibrosis. 23124075 2013
Entrez Id: 6046
Gene Symbol: BRD2
BRD2
0.010 GeneticVariation disease BEFREE Heterozygous XRCC3 codon 241 [OR 2.07 (1.05-4.06)], homozygous variant of NAT C481T [OR 2.81 (1.09-7.21)], and both heterozygous and homozygous variants of NAT codon 268 and 286 [OR 2.31 (1.20-4.45) and 4.98 (1.87-13.14), and 6.12 (2.75-13.62) and 2.65 (1.04-6.72)] individually influenced susceptibility to OSF in the population. 22092501 2012
Entrez Id: 3123
Gene Symbol: HLA-DRB1
HLA-DRB1
0.010 GeneticVariation disease BEFREE The analysis of HLA-A, -B, and -C antigens, and of HLA-DRB1 and -DQB1 alleles in OSF patients and healthy control subjects, was performed by serologic typing and DNA typing using polymerase chain reaction with sequence-specific primers (PCR-SSP), respectively. 15061705 2004
Entrez Id: 355
Gene Symbol: FAS
FAS
0.010 GeneticVariation disease BEFREE Multivariate logistic regression analysis indicated that FAS A(-1377)-G(-670) vs. G(-1377)-A(-670) haplotype (OR = 2.26, 95% CI = 1.16-4.41) was correlated with the malignant potential of OSF. 20359312 2010
Entrez Id: 356
Gene Symbol: FASLG
FASLG
0.010 GeneticVariation disease BEFREE Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis was used to determine the FAS and FASL polymorphisms in 294 oral squamous cell carcinoma (OSCC), 53 oral submucous fibrosis (OSF), and 84 oral leukoplakia (OL) patients, as well as in 333 healthy controls. 20359312 2010
Entrez Id: 841
Gene Symbol: CASP8
CASP8
0.010 GeneticVariation disease BEFREE The identification of mutations in OSCC lesions but not OSMF suggests that dimer forming domain mutations in caspase 8 may be limited to malignant lesions. 26107208 2015
Entrez Id: 373156
Gene Symbol: GSTK1
GSTK1
0.010 GeneticVariation disease BEFREE This study establishes a distinct quantitative difference between normal oral mucosa (NOM) and OSF in respect to their histological features and GST null gene frequencies. 18573513 2008
Entrez Id: 10
Gene Symbol: NAT2
NAT2
0.010 GeneticVariation disease BEFREE Gene-gene interaction analysis by multifactor dimensionality reduction (MDR) revealed that XRCC3 Thr 241 Met had the largest univariate effect followed by XRCC3 Thr 241 Met - NAT2 A857G in men that presents a highly synergistic interaction as one of the potential combinations of single nucleotide polymorphisms (SNPs) to increase the risk of OSF in men if exposed to arecanut or smokeless tobacco usage. 22092501 2012
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.010 GeneticVariation disease BEFREE This study establishes a distinct quantitative difference between normal oral mucosa (NOM) and OSF in respect to their histological features and GST null gene frequencies. 18573513 2008
Entrez Id: 574501
Gene Symbol: MIR499A
MIR499A
0.010 GeneticVariation disease BEFREE The T/C+C/C genotypes of MiR-499a may contribute to an increased risk of BQ-related OSF, but a decreased risk of OSCC. miR-499a T>C influences the expression levels of miR-499a-5p during the tumorigenesis of OSCC. 24690080 2015
Entrez Id: 4792
Gene Symbol: NFKBIA
NFKBIA
0.010 GeneticVariation disease BEFREE Chromosomal DNA isolated from twenty five each of OSMF and OL tissue biopsy samples were subjected to PCR amplification with intronic primers flanking twenty four exons of the NFKB gene. 27510021 2016
Entrez Id: 7517
Gene Symbol: XRCC3
XRCC3
0.010 GeneticVariation disease BEFREE Gene-gene interaction analysis by multifactor dimensionality reduction (MDR) revealed that XRCC3 Thr 241 Met had the largest univariate effect followed by XRCC3 Thr 241 Met - NAT2 A857G in men that presents a highly synergistic interaction as one of the potential combinations of single nucleotide polymorphisms (SNPs) to increase the risk of OSF in men if exposed to arecanut or smokeless tobacco usage. 22092501 2012
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.360 Biomarker disease BEFREE Evaluation of transforming growth factor beta1 gene in oral submucous fibrosis induced in Sprague-Dawley rats by injections of areca nut and pan masala (commercial areca nut product) extracts. 27072267 2016
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.360 Biomarker disease CTD_human Oral submucous fibrosis: review on aetiology and pathogenesis. 16311067 2006
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.360 Biomarker disease BEFREE Egr-1 is a key mediator in TGF-β1-induced pathogenesis of OSF. 26922429 2017
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.360 Biomarker disease BEFREE These experimental in vitro findings were confirmed using human clinical samples, where we showed that the stroma of OSF contained myofibroblasts and that TGF-β1-dependent Smad signalling was detectable both in keratinocytes and in myofibroblasts. 21171082 2011
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.330 Biomarker disease CTD_human Oral submucous fibrosis: review on aetiology and pathogenesis. 16311067 2006
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.330 Biomarker disease BEFREE This study compares the hypermethylation status of E-cadherin and COX-2 genes in patients with oral cancer and patients with OSF and also aims to identify risk factors for the development of OSF. 23250779 2012
Entrez Id: 4318
Gene Symbol: MMP9
MMP9
0.330 Biomarker disease CTD_human Oral submucous fibrosis: review on aetiology and pathogenesis. 16311067 2006
Entrez Id: 6935
Gene Symbol: ZEB1
ZEB1
0.330 Biomarker disease CTD_human Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression. 26934322 2016
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
0.320 Biomarker disease CTD_human Oral submucous fibrosis: review on aetiology and pathogenesis. 16311067 2006
Entrez Id: 1278
Gene Symbol: COL1A2
COL1A2
0.320 Biomarker disease CTD_human Oral submucous fibrosis: review on aetiology and pathogenesis. 16311067 2006